1. Medtech Insight
  2. >>Market Intelligence

Medtech Insight Company Rankings 2025

MTI100 Archive

Medtech Insight’s MTI 100 comprises a set of industry league tables providing US dollar rankings of medtech companies according to their overall annual medical device and IVD revenues where appropriate, and product sector-specific revenues where possible.

Deloitte 2025 Life Sciences Outlook Report Finds Medtech Leaders Focus On AI, GenAI Adoption Across Value Chain To Increase Efficiencies, Cut Costs

By Marion Webb

The Deloitte 2025 Life Sciences Outlook report highlights cautious optimism among life sciences and medtech executives, with 75% expressing confidence in revenue growth despite challenges. AI and digital transformation are central to their strategies, enabling cost savings and operational efficiencies. Medtech Insight also spoke with Deloitte’s US Consulting Medtech Practice Leader, Sheryl Jacobson, about her medtech outlook for 2025.

The 2023 MTI 100 list reflects a below-average level of M&A activity. The threshold for inclusion rose to half a billion US dollars for the first time. Several new names – many of them China-based IVD and other medical device manufacturers – have entered the lower reaches of the Top 100.

The table also reflects the winding out of COVID-based revenues, especially among IVD players – with the top ten companies Abbott and Roche the most visible examples of this.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?